Tecentriq Hybreza 50242-0933-86
Generic: Atezolizumab And Hyaluronidase-Tqjs
- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 12, 2024
- Listing Expires
- December 31, 2027
- Application
- BLA761347
Need to source Tecentriq Hybreza? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Atezolizumab | 1875 mg/15mL |
| Hyaluronidase (human Recombinant) | 30000 U/15mL |
Drug Class
Programmed Death Receptor-1 Blocking Antibody [EPC]Endoglycosidase [EPC]Antibodies [CS]
Selected Package
50242-0933-86Selected1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-86) / 15 mL in 1 VIAL, SINGLE-DOSE
Other packages for this product(1)
1 VIAL, SINGLE-DOSE in 1 BOX (50242-933-01) / 15 mL in 1 VIAL, SINGLE-DOSE